In all, and based on the above overview of BCP’s cytotoxic effect in normal and cancer cells, BCP may selectively target cancer cells over normal ones, potentially allowing for an effective cancer treatment with reduced side effects. The gene discussed is OPN1SW; the disease is cancer.